Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)
K-Number: K181807 · 2019-03-06
Device Summary
Frequently Asked Questions
What is the Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)?
Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) is a medical device that received FDA 510(k) clearance on 2019-03-06. It is manufactured by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular. The 510(k) number is K181807.
When was Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) approved by the FDA?
Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) received FDA 510(k) clearance on 2019-03-06, under approval number K181807.
What company makes Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)?
Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) is manufactured by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular.
What is the FDA product code for Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)?
The FDA product code for Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) is POL.
Related Clinical Trials
Other Devices by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Related Devices (Code: POL)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.